The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease
Open accessAbstract
CD39/ENTPD1 hydrolyzes proinflammatory nucleotides to generate adenosine. As purinergic mediators have been implicated in intestinal inflammation, we hypothesized that CD39 might protect against inflammatory bowel disease. We studied these possibilities in a mouse model of colitis using mice with global CD39 deletion. We then tested whether human genetic polymorphisms in the CD39 gene might influence susceptibility to Crohn's disease. We induced colitis in mice using Dextran Sodium Sulfate (DSS). Readouts included disease activity scores, histological evidence of injury, and markers of inflammatory activity. We used HapMap cell lines to find SNPs that tag for CD39 expression, and then compared the frequency of subjects with high vs. low CD39-expression genotypes in a case-control cohort for Crohn's disease. Mice null for CD39 were highly susceptible to DSS injury, with heterozygote mice showing an intermediate phenotype compared to wild type (WT). We identified a common SNP that tags CD39 mRNA expression levels in man. The SNP tagging low levels of CD39 expression was associated with increased susceptibility to Crohn's disease in a case-control cohort comprised of 1,748 Crohn's patients and 2,936 controls ( P = 0.005–0.0006). Our data indicate that CD39 deficiency exacerbates murine colitis and suggest that CD39 polymorphisms are associated with inflammatory bowel disease in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with these in vitro observations, individuals with reduced ability to transcribe CD39 due to a promoter polymorphism (Friedman et al., 2009) have better responses to TIV as well as VZV vaccination”
From Successful and Maladaptive T Cell Aging (2017) · cites this paper as Friedman et al., 2009
In the citing paper
“In humans, polymorphisms of ENTPD1 were shown to be associated with IBD, and expression of P2X7 was increased in the intestinal epithelium and lamina propria of IBD patients (Friedman et al., 2009; Neves et al., 2014).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Friedman et al., 2009
In the citing paper
“Entpd1−/− mice, which cannot remove extracellular ATP through this mechanism, where highly susceptible to experimental colitis (Friedman et al., 2009).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Friedman et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Cryopyrin activates the inflammasome in response to toxins and ATP
Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature · doi:10.1038/nature04515 · Cited by 3,080
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,613
Self-citationPopulation genomics of human gene expression
Stranger, B. E., Nica, A. C., Forrest, M. S., Dimas, A. S., Bird, C., Beazley, C., Ingle, C., Dunning, M., Flicek, P., Koller, D., et al. (2007) · Nature Genetics · doi:10.1038/ng2142 · Cited by 1,153
ATP drives lamina propria TH17 cell differentiation
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y., Yamamoto, M., Onoue, M., Yagita, H., Ishii, N., Evans, R., Honda, K., et al. (2008) · Nature · doi:10.1038/nature07240 · Cited by 1,089
A genome-wide association study of global gene expression
Dixon, A. L., Liang, L., Moffatt, M. F., Chen, W., Heath, S. C., Wong, K., Taylor, J. C., Burnett, E. C., Gut, I. G., Farrall, M., et al. (2007) · Nature Genetics · doi:10.1038/ng2109 · Cited by 946
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940
Robson, S. C., Sévigny, J., & Zimmermann, H. (2006) · Purinergic Signalling · doi:10.1007/s11302-006-9003-5 · Cited by 930
Self-citationTysk, C., Lindberg, E. H., Järnerot, G., & FLODERUS-MYRHED, B. (1988) · Gut · doi:10.1136/gut.29.7.990 · Cited by 828
Research works printed but not linked: 1
- 10.2337/db07-1265 · DOI
Cited by
Sorted by citations
Eltzschig, H. K., & Carmeliet, P. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0910283 · Cited by 2,061
CD39 and CD73 in immunity and inflammation
Antonioli, L., Pacher, P., Vizi, E. S., & Haskó, G. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.03.005 · Cited by 1,269
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 930
Postler, T. S., & Ghosh, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.008 · Cited by 876
“Entpd1 / mice, which cannot remove extracellular ATP through this mechanism, were highly susceptible to experimental colitis (Friedman et al., 2009).”
BackgroundInteraction Between the Microbiota, Epithelia, and Immune Cells in the Intestine
Kayama, H., Okumura, R., & Takeda, K. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-070119-115104 · Cited by 784
Purinergic Signaling during Inflammation
Eltzschig, H. K., Sitkovsky, M. V., & Robson, S. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1205750 · Cited by 739
Self-citationPurinergic Signaling during Inflammation
Eltzschig, H. K., Mv, S., & Robson, S. C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1300259 · Cited by 609
Self-citationThe adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 621
Extracellular adenosine triphosphate and adenosine in cancer
Stagg, J., & Smyth, M. J. (2010) · Oncogene · doi:10.1038/onc.2010.292 · Cited by 590
Activation of neuronal P2X7 receptor–pannexin-1 mediates death of enteric neurons during colitis
Gulbransen, B. D., Bashashati, M., Hirota, S. A., Gui, X. S., Roberts, J. A., MacDonald, J. A., Muruve, D. A., McKay, D. M., Beck, P. L., Mawe, G. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2679 · Cited by 444
Successful and Maladaptive T Cell Aging
Goronzy, J. J., & Weyand, C. M. (2017) · Immunity · doi:10.1016/j.immuni.2017.03.010 · Cited by 362
Moesta, A. K., Li, X.-Y., & Smyth, M. J. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0376-4 · Cited by 332
Huang, B., Chen, Z., Geng, L., Wang, J., Liang, H., Cao, Y., Chen, H., Huang, W., Su, M., Wang, H., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.027 · Cited by 309
Yegutkin, G. G. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2014.953627 · Cited by 299
Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies
Kim, D. H., & Cheon, J. H. (2017) · Immune Network · doi:10.4110/in.2017.17.1.25 · Cited by 295
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2023 · Cited by 286
Telesford, K. M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M. A., Begum-Haque, S., Kasper, D. L., & Kasper, L. H. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1056973 · Cited by 252
Ectonucleotidases as Regulators of Purinergic Signaling in Thrombosis, Inflammation, and Immunity
Deaglio, S., & Robson, S. C. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00010-2 · Cited by 258
Self-citationExtracellular ATP: A Feasible Target for Cancer Therapy
Vultaggio-Poma, V., Sarti, A. C., & Virgilio, F. D. (2020) · Cells · doi:10.3390/cells9112496 · Cited by 259
The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD
Steinbach, E. C., & Plevy, S. E. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e3182a69dca · Cited by 269
Extracellular nucleotides and nucleosides as signalling molecules
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2018) · Immunology Letters · doi:10.1016/j.imlet.2018.11.006 · Cited by 230
Extracellular ATP and adenosine: The Yin and Yang in immune responses?
Faas, M. M., Sáez, T., & de Vos, P. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.01.002 · Cited by 216
ENTPD1/CD39 is a promising therapeutic target in oncology
Bastid, J., Regairaz, A., Alberici, G. F., Bonnefoy, N., Eliaou, J.-F., & Bensussan, A. (2012) · Oncogene · doi:10.1038/onc.2012.269 · Cited by 213
Much Ado about Adenosine: Adenosine Synthesis and Function in Regulatory T Cell Biology
Ernst, P. B., Garrison, J. C., & Thompson, L. F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000108 · Cited by 212
Grant, C. R., Liberal, R., Holder, B. S., Cardone, J., Ma, Y., Robson, S. C., Mieli‐Vergani, G., Vergani, D., & Longhi, M. S. (2013) · Hepatology · doi:10.1002/hep.26583 · Cited by 189
Self-citationCD39 Regulation and Functions in T Cells
Timperi, E., & Barnaba, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158068 · Cited by 191
External influences on the immune system via activation of the aryl hydrocarbon receptor
Stockinger, B., Hirota, K., Duarte, J. H., & Veldhoen, M. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.008 · Cited by 190
CD39/Adenosine Pathway Is Involved in AIDS Progression
Nikolova, M. H., Carrière, M., Jenabian, M.-A., Limou, S., Younas, M., Kök, A., Hüe, S., Seddiki, N., Hulin, A., Delaneau, O., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002110 · Cited by 186
The resurgence of A2B adenosine receptor signaling
Aherne, C. M., Kewley, E. M., & Eltzschig, H. K. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.05.016 · Cited by 162
Antonioli, L., Blandizzi, C., Pacher, P., & Haskó, G. (2019) · Pharmacological Reviews · doi:10.1124/pr.117.014878 · Cited by 163
Park, Y., Kim, N., Shim, Y. K., Choi, Y. J., Nam, R. H., Choi, Y. J., Ham, M. H., Suh, J. H., Lee, S. M., Lee, C. M., et al. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.4.260 · Cited by 151
Impact of Ectoenzymes on P2 and P1 Receptor Signaling
Kukulski, F., Lévesque, S. A., & Sévigny, J. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00009-6 · Cited by 143
Kaku, H., Cheng, K. F., Al‐Abed, Y., & Rothstein, T. L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400336 · Cited by 143
Expression of CD39 on activated T cells impairs their survival in older individuals
Fang, F., Yu, M., Cavanagh, M. M., Hutter Saunders, J., Qi, Q., Ye, Z., Le Saux, S., Sultan, W., Turgano, E., Dekker, C. L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.01.002 · Cited by 138
“Variable expression in humans has been attributed to an A-to-G SNP at position rs_10748643 (Friedman et al., 2009).”
Hypoxia and hyperbaric oxygen therapy: a review
Choudhury, R. (2018) · International Journal of General Medicine · doi:10.2147/ijgm.s172460 · Cited by 149
Extracellular nucleotide and nucleoside signaling in vascular and blood disease
Idzko, M., Ferrari, D., Riegel, A.-K., & Eltzschig, H. K. (2014) · Blood · doi:10.1182/blood-2013-09-402560 · Cited by 135
On the mechanism of anti-CD39 immune checkpoint therapy
Allard, D., Allard, B., & Stagg, J. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2019-000186 · Cited by 136
Adenosine signaling during acute and chronic disease states
Karmouty‐Quintana, H., Xia, Y., & Blackburn, M. R. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-0997-1 · Cited by 130
Making sense of regulatory T cell suppressive function
Shalev, I., Schmelzle, M., Robson, S. C., & Levy, G. A. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.003 · Cited by 121
Self-citationAdenosine and Hypoxia-Inducible Factor Signaling in Intestinal Injury and Recovery
Colgan, S. P., & Eltzschig, H. K. (2011) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020911-153230 · Cited by 123
Poth, J. M., Brodsky, K. S., Ehrentraut, H., Grenz, A., & Eltzschig, H. K. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0988-7 · Cited by 125
Purinergic Signaling in Pulmonary Inflammation
Le, T. T., Berg, N. K., Harting, M. T., Li, X., Eltzschig, H. K., & Yuan, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01633 · Cited by 122
The hypoxia-adenosine link during inflammation
Bowser, J. L., Lee, J. W., Yuan, X., & Eltzschig, H. K. (2017) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00101.2017 · Cited by 118
NTPDase1 governs P2X7‐dependent functions in murine macrophages
Lévesque, S. A., Kukulski, F., Enjyoji, K., Robson, S. C., & Sévigny, J. (2010) · European Journal of Immunology · doi:10.1002/eji.200939741 · Cited by 112
Self-citationTransgenic swine: Expression of human CD39 protects against myocardial injury
Wheeler, D. G., Joseph, M. E., Mahamud, S. D., Aurand, W. L., Mohler, P. J., Pompili, V. J., Dwyer, K. M., Nottle, M. B., Harrison, S. J., d’Apice, A. J. F., et al. (2012) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2012.01.002 · Cited by 109
Self-citationMolecular Signaling and Dysfunction of the Human Reactive Enteric Glial Cell Phenotype
Liñán-Rico, A., Turco, F., Ochoa‐Cortés, F., Harzman, A. E., NEEDLEMAN, B. J., Arsenescu, R. I., Abdel‐Rasoul, M., Fadda, P., Grants, I. S., Whitaker, E. E., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000854 · Cited by 105
Liu, M., Zhang, X., Hao, Y., Ding, J., Shen, J., Xue, Z., Wei, Q., Li, Z.-Y., Song, Y., Zhang, T., et al. (2019) · Food & Function · doi:10.1039/c8fo02301h · Cited by 107
Aherne, C. M., Saeedi, B. J., Collins, C. B., Masterson, J. C., McNamee, E. N., Perrenoud, L., Rapp, C., Curtis, V. F., Bayless, A., Fletcher, A., et al. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.22 · Cited by 99
The A2B Adenosine Receptor Promotes Th17 Differentiation via Stimulation of Dendritic Cell IL-6
Wilson, J. M., Kurtz, C. C., Black, S. G., Ross, W. G., Alam, M. S., Linden, J. M., & Ernst, P. B. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100117 · Cited by 97
Purinergic signaling during intestinal inflammation
Longhi, M. S., Moss, A. C., Jiang, Z. G., & Robson, S. C. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1545-1 · Cited by 99
Self-citationHai, Z., Bo, C., Kang, Y., & Li, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00727 · Cited by 98
Tsai, S. H., Kinoshita, M., Kusu, T., Kayama, H., Okumura, R., Ikeda, K., Shimada, Y., Takeda, A., Yoshikawa, S., Obata‐Ninomiya, K., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.015 · Cited by 93
Bilirubin suppresses Th17 immunity in colitis by upregulating CD39
Longhi, M. S., Vuerich, M., Kalbasi, A., Kenison, J. E., Yeste, A., Csizmadia, E., Vaughn, B. P., Feldbrügge, L., Mitshuhashi, S., Wegiel, B., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92791 · Cited by 94
Self-citationTargeting Hypoxia Signaling for Perioperative Organ Injury
Yuan, X., Lee, J. W., Bowser, J. L., Neudecker, V., Sridhar, S., & Eltzschig, H. K. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002288 · Cited by 95
Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases
Huang, C., Zhu, H., Yao, Y., Bian, Z.-H., Zheng, Y.-J., Li, L., Moutsopoulos, H. Μ., Gershwin, M. E., & Lian, Z. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102333 · Cited by 94
CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
Harvey, J. B., Phan, L. H., Villarreal, O. E., & Bowser, J. L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00508 · Cited by 88
Rissiek, A., Baumann, I., Cuapio, A., Mautner, A., Kolster, M., Arck, P., Dodge‐Khatami, A., Mittrücker, H., Koch‐Nolte, F., Haag, F., et al. (2015) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.12.007 · Cited by 88
Chang, Z., Liu, H.-M., Leu, Y., Hsu, C.-H., & Lee, T.-Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052667 · Cited by 92
Extracellular ATP mediates inflammatory responses in colitis via P2 × 7 receptor signaling
Wan, P., Liu, X., Xiong, Y., Ren, Y., Jiang, C., Lü, N., Guo, Y., & Bai, A. (2016) · Scientific Reports · doi:10.1038/srep19108 · Cited by 83
Bai, A., Moss, A. C., Rothweiler, S., Longhi, M. S., Wu, Y., JUNGER, W. G., & Robson, S. C. (2015) · Nature Communications · doi:10.1038/ncomms9819 · Cited by 84
Self-citationHypoxia and inflammatory bowel disease
Cummins, E. P., & Crean, D. (2016) · Microbes and Infection · doi:10.1016/j.micinf.2016.09.004 · Cited by 88
Timperi, E., Pacella, I., Schinzari, V., Focaccetti, C., Sacco, L., Farelli, F., Caronna, R., Bene, G. D., Longo, F., Ciardi, A., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1175800 · Cited by 86
Longhi, M. S., Robson, S. C., Bernstein, S. H., Serra, S., & Deaglio, S. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0991-z · Cited by 79
Self-citationZebisch, M., Krauss, M., Schäfer, P., & Sträter, N. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.10.050 · Cited by 77
Deficient Resident Memory T Cell and CD8 T Cell Response to Commensals in Inflammatory Bowel Disease
Noble, A., Durant, L. R., Hoyles, L., McCartney, A. L., Man, R., Segal, J. P., Costello, S. P., Hendy, P., Reddi, D., Bouri, S., et al. (2019) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjz175 · Cited by 79
Ectonucleotidases in Acute and Chronic Inflammation
Giuliani, A. L., Sarti, A. C., & Virgilio, F. D. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.619458 · Cited by 83
Wang, Y., Ji, X., Yan, M., Chen, X., Kang, M., Teng, L., Wu, X., Chen, J., & Deng, C. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.08.198 · Cited by 74
Kusu, T., Kayama, H., Kinoshita, M., Jeon, S. G., Ueda, Y., Goto, Y., Okumura, R., Saiga, H., Kurakawa, T., Ikeda, K., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1103067 · Cited by 73
Gu, B. J., Field, J., Dutertre, S., Ou, A., Kilpatrick, T. J., Lechner‐Scott, J., Scott, R. J., Lea, R. A., Taylor, B. V., Stankovich, J. M., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv278 · Cited by 73
Longhi, M. S., Moss, A. C., Bai, A., Wu, Y., Huang, H., Cheifetz, A. S., Quintana, F. J., & Robson, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087956 · Cited by 76
Self-citationCD 73 is a phenotypic marker of effector memory T h17 cells in inflammatory bowel disease
Doherty, G. A., Bai, A., Hanidziar, D., Longhi, M. S., Lawlor, G. O., Putheti, P., Csizmadia, E., Nowak, M., Cheifetz, A. S., Moss, A. C., et al. (2012) · European Journal of Immunology · doi:10.1002/eji.201242623 · Cited by 68
Self-citationLongitudinal Immune Responses and Gene Expression Profiles in Type 1 Leprosy Reactions
Geluk, A., van Meijgaarden, K. E., Wilson, L., Bobosha, K., Schip, J. J. V. D. P.-V., van den Eeden, S. J. F., Quinten, E., Dijkman, K., Franken, K. L. M. C., Haisma, E. M., et al. (2013) · Journal of Clinical Immunology · doi:10.1007/s10875-013-9979-x · Cited by 68
Oral delivery of layer-by-layer coated exosomes for colitis therapy
Deng, C., Hu, Y., Conceição, M., Wood, M. J. A., Zhong, H., Wang, Y., Shao, P., Chen, J., & Qiu, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.017 · Cited by 71
Purinergic Signaling in Gut Inflammation: The Role of Connexins and Pannexins
Diezmos, E. F., Bertrand, P. P., & Liu, L. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00311 · Cited by 67
Liu, M., Ding, J., Zhang, H., Shen, J., Hao, Y., Zhang, X., Wei, Q., Luo, X., Zhang, T., & Wang, N. (2020) · Food & Function · doi:10.1039/d0fo00546k · Cited by 66
CD73 Is Critical for the Resolution of Murine Colonic Inflammation
Bynoe, M. S., Waickman, A. T., Mahamed, D., Mueller, C., Mills, J. H., & Czopik, A. K. (2012) · BioMed Research International · doi:10.1155/2012/260983 · Cited by 65
Gibson, D. J., Elliott, L., McDermott, E., Tosetto, M., Keegan, D., Byrne, K., Martin, S. T., Rispens, T., Cullen, G., Mulcahy, H. E., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000566 · Cited by 62
Self-citationLu, S., Liu, Y., Tang, S., Zhang, W., Yu, Q., Shi, C., & Cheong, K. (2021) · Food Chemistry X · doi:10.1016/j.fochx.2021.100197 · Cited by 64
Coordination of ENT2-dependent adenosine transport and signaling dampens mucosal inflammation
Aherne, C. M., Collins, C. B., Rapp, C., Olli, K. E., Perrenoud, L., Jedlicka, P., Bowser, J. L., Mills, T., Karmouty‐Quintana, H., Blackburn, M. R., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121521 · Cited by 63
Regulation of immune responses through CD39 and CD73 in cancer: Novel checkpoints
Baghbani, E., Noorolyai, S., Shanehbandi, D., Mokhtarzadeh, A., Maleki, L. A., Khaze, V., Brunetti, O., Rahmani, S., Shadbad, M. A., Baghbanzadeh, A., et al. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119826 · Cited by 64
Epithelial IFNγ signalling and compartmentalized antigen presentation orchestrate gut immunity
Malik, A., Sharma, D., Aguirre‐Gamboa, R., McGrath, S., Zabala, S., Weber, C. R., & Jabrì, B. (2023) · Nature · doi:10.1038/s41586-023-06721-1 · Cited by 63
NTPDase1 Controls IL-8 Production by Human Neutrophils
Kukulski, F., Bahrami, F., Yebdri, F. B., Lecka, J., Martı́n-Satué, M., Lévesque, S. A., & Sévigny, J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002680 · Cited by 63
Raczkowski, F., Rissiek, A., Ricklefs, I., Heiß, K., Schumacher, V., Wundenberg, K., Haag, F., Koch‐Nolte, F., Tolosa, E., & Mittrücker, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197151 · Cited by 65
Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal
Khadge, S., Banu, S., Bobosha, K., Schip, J. J. V. D. P.-V., Goulart, I. M. B., Thapa, P., Kunwar, C. B., van Meijgaarden, K. E., van den Eeden, S. J. F., Wilson, L., et al. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1128-0 · Cited by 62
Disrupted regulatory T cell homeostasis in inflammatory bowel diseases
Pedros, C. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i3.974 · Cited by 63
Hypoxia signaling during intestinal ischemia and inflammation
Grenz, A., Clambey, E. T., & Eltzschig, H. K. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283514bd0 · Cited by 60
Purine metabolism controls innate lymphoid cell function and protects against intestinal injury
Crittenden, S., Cheyne, A., Adams, A. T., Forster, T., Robb, C. T., Felton, J. M., Ho, G., Rückerl, D., Rossi, A. G., Anderton, S. M., et al. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12167 · Cited by 60
The Hypoxia–Adenosine Link during Intestinal Inflammation
Bowser, J. L., Phan, L. H., & Eltzschig, H. K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701414 · Cited by 62
Signalling by extracellular nucleotides in health and disease
Vultaggio-Poma, V., Falzoni, S., Salvi, G., Giuliani, A. L., & Virgilio, F. D. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119237 · Cited by 59
Zhang, Y., Hu, J., Ji, K., Jiang, S., Dong, Y., Sun, L., Wang, J., Hu, G., Chen, D., Chen, K., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101151 · Cited by 63
Chewning, J. H., & Weaver, C. T. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401835 · Cited by 62
Price, G. W., Chadjichristos, C. E., Kavvadas, P., Tang, S. C. W., Yiu, W. H., Green, C. R., Potter, J. A., Siamantouras, E., Squires, P. E., & Hills, C. E. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00558-1 · Cited by 58
Potential for Developing Purinergic Drugs for Gastrointestinal Diseases
Ochoa‐Cortés, F., Liñán-Rico, A., Jacobson, K. A., & Christofi, F. L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000047 · Cited by 60
Jarvis, L. B., Rainbow, D. B., Coppard, V., Howlett, S., Georgieva, Z. G., Davies, J. L., Mullay, H. K., Hester, J., Ashmore, T., van den Bosch, A. M. R., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02721-x · Cited by 60
Sharpen, J. D. A., Dolan, B., Nyström, E. E. L., Birchenough, G. M. H., Arike, L., Martínez‐Abad, B., Johansson, M., Hansson, G. C., & Recktenwald, C. V. (2022) · Nature Communications · doi:10.1038/s41467-021-27743-1 · Cited by 53
Purine and purinergic receptors in health and disease
Ai, Y., Wang, H., Liu, L., Qi, Y., Tang, S., Tang, J., & Chen, N. (2023) · MedComm · doi:10.1002/mco2.359 · Cited by 57
Pfalzer, A. C., Nesbeth, P.-D. C., Parnell, L. D., Iyer, L. K., Liu, Z., Kane, A. V., Chen, C. O., Tai, A., Bowman, T. A., Obin, M. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135758 · Cited by 55
HIF-1α-induced xenobiotic transporters promote Th17 responses in Crohn's disease
Xie, A., Robles, R. J., Mukherjee, S., Zhang, H., Feldbrügge, L., Csizmadia, E., Wu, Y., Enjyoji, K., Moss, A. C., Otterbein, L. E., et al. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.07.022 · Cited by 53
Self-citationExacerbated intestinal inflammation in P2Y6 deficient mice is associated with Th17 activation
Salem, M., Azreq, M.-A. E., Pelletier, J., Robaye, B., Aoudjit, F., & Sévigny, J. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.019 · Cited by 52
Salem, M., Lecka, J., Pelletier, J., Marconato, D. G., Dumas, A., Vallières, L., Brochu, G., Robaye, B., Jobin, C., & Sévigny, J. (2021) · Gut · doi:10.1136/gutjnl-2020-320937 · Cited by 52
Metadata
- Authors
- Friedman, D. J., Künzli, B. M., A-Rahim, Y. I., Sevigny, J., Berberat, P. O., Enjyoji, K., Csizmadia, E., Friess, H., & Robson, S. C.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- University of Hawaiʻi at Mānoa (US)
- Transplantation Center and Gastroenterology Division, Beth Israel Deaconess Medical Center, Harvard University, 330 Brookline Avenue, Boston, MA 02215;
- Technical University of Munich (DE)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-09-29
- Volume
- 106
- Issue
- 39
- Pages
- 16788-16793
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2757811
- OpenAlex
- W2163178183
- Cited by
- 284
- References
- 40
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 15 · 2020: 25 · 2019: 23 · 2018: 15 · 2017: 20 · 2016: 18 · 2015: 20 · 2014: 20 · 2013: 15 · 2012: 21
- FWCI
- 8.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Wellcome Trust
- National Institutes of Health (5p01hl076540-10)
- National Heart, Lung, and Blood Institute (HL-57307, HL63972, HL 076540, R01HL094400, P01 HL-076540, R01HL057307, R01HL063972)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK076868)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- CD39, adenosine, purinergic signaling, inflammatory bowel disease, Crohn's disease, colitis, DSS-induced colitis, genetic polymorphism, single nucleotide polymorphisms, genetic susceptibility, nucleotide hydrolysis
- MeSH terms
- Animals, Apyrase, Colitis, Crohn Disease, Disease Models, Animal, Genotype, Humans, Mice, Inbred C57BL, Polymorphism, Genetic, RNA, Messenger, Inflammatory Bowel Diseases, Antigens, CD, Sequence Deletion, Genetic Predisposition to Disease, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
